Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Exploring the relationship between schizophrenia and cardiovascular disease: A genetic correlation and multivariable Mendelian randomization study

Rada R Veeneman, Jentien M Vermeulen, Abdel Abdellaoui, View ORCID ProfileEleanor Sanderson, Robyn E Wootton, Rafik Tadros, Connie R Bezzina, Damiaan Denys, Marcus R Munafò, Karin JH Verweij, Jorien L Treur
doi: https://doi.org/10.1101/2021.07.09.21260260
Rada R Veeneman
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jentien M Vermeulen
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdel Abdellaoui
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor Sanderson
2MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eleanor Sanderson
Robyn E Wootton
3MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Nic Waals institute, Lovisenberg Diaconal Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafik Tadros
4Cardiovascular Genetics Center, Montreal Heart Institute, Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada; Department of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Connie R Bezzina
5Department of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damiaan Denys
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus R Munafò
6MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; School of Psychological Science, University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin JH Verweij
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorien L Treur
1Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.l.treur{at}amsterdamumc.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Individuals with schizophrenia have a reduced life-expectancy compared to the general population, largely due to an increased risk of cardiovascular disease (CVD). Clinical and epidemiological studies have been unable to fully unravel the nature of this relationship.

Objective Investigate genetic correlations and potential bi-directional effects between liability to schizophrenia and CVD.

Design, setting, and participants We obtained summary-data of genome-wide-association studies of schizophrenia (N=130,644), heart failure (N=977,323), coronary artery disease (N=332,477), systolic and diastolic blood pressure (N=757,601), heart rate variability (N=46,952), QT interval (N=103,331), early repolarization and dilated cardiomyopathy ECG patterns (N=63,700). We computed genetic correlations with linkage disequilibrium score regression and conducted bi-directional Mendelian randomization (MR). With multivariable MR, we investigated whether associations were mediated by smoking, body mass index, physical activity, lipid levels, or type 2 diabetes. To ensure robustness, we applied a range of sensitivity methods.

Main outcomes and measures Schizophrenia, heart failure, coronary artery disease, systolic blood pressure, diastolic blood pressure, heart rate variability, QT interval, early repolarization, dilated cardiomyopathy.

Results Genetic correlations between liability to schizophrenia and CVD were close to zero (−0.02 to 0.04). With MR, we found robust evidence that liability to schizophrenia increases heart failure risk. This effect remained consistent with multivariable MR. There was also evidence that liability to schizophrenia increases early repolarization risk, largely mediated by BMI and lipid levels. Finally, there was evidence that liability to schizophrenia increases heart rate variability, a direction of effect contrasting previous studies. In the other direction, there was weak evidence that higher systolic, but not diastolic, blood pressure increases schizophrenia risk.

Conclusions and relevance Our findings indicate that liability to schizophrenia increases the risk of heart failure, and that this is not mediated by key health behaviours. This is consistent with the notion that schizophrenia is characterised by a systemic dysregulation of the body (including inflammation and oxidative stress) with detrimental effects on the heart. To decrease cardiovascular mortality among schizophrenia patients, priority should lie with optimal treatment and interventions in early stages of psychoses. We also identified early repolarization, currently understudied, as a potential CVD marker among patients with schizophrenia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JLT is supported by a Young Investigator (NARSAD) Grant from the Brain & Behaviour Research Foundation. Specifically, the current work was made possible by the Evelyn Toll Family Foundation, whom we would like to greatly acknowledge for their support. KJHV, AA, and JLT are also supported by the Foundation Volksbond Rotterdam. AA is supported by ZonMw grant 849200011 from The Netherlands Organisation for Health Research and Development. We acknowledge SURFsara for the usage of the Lisa cluster computer (supported by NWO, 15725). CRB was supported by the Dutch Heart Foundation Netherlands Cardiovascular Research Initiative (CVON; PREDICT2 2018-30). MRM is a member of the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7), and the National Institute for Health Research (NIHR) Biomedical Research Centre at the University Hospitals Bristol National Health Service (NHS) Foundation Trust, and the University of Bristol. REW is supported by a postdoctoral fellowship from the South-Eastern Regional Health Authority (2020024).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not relevant as these analyses were based on anonymous, summary-level data of large-scale public datasets

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All analyses in this study were based on publicly available (summary-level) GWAS data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Exploring the relationship between schizophrenia and cardiovascular disease: A genetic correlation and multivariable Mendelian randomization study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Exploring the relationship between schizophrenia and cardiovascular disease: A genetic correlation and multivariable Mendelian randomization study
Rada R Veeneman, Jentien M Vermeulen, Abdel Abdellaoui, Eleanor Sanderson, Robyn E Wootton, Rafik Tadros, Connie R Bezzina, Damiaan Denys, Marcus R Munafò, Karin JH Verweij, Jorien L Treur
medRxiv 2021.07.09.21260260; doi: https://doi.org/10.1101/2021.07.09.21260260
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Exploring the relationship between schizophrenia and cardiovascular disease: A genetic correlation and multivariable Mendelian randomization study
Rada R Veeneman, Jentien M Vermeulen, Abdel Abdellaoui, Eleanor Sanderson, Robyn E Wootton, Rafik Tadros, Connie R Bezzina, Damiaan Denys, Marcus R Munafò, Karin JH Verweij, Jorien L Treur
medRxiv 2021.07.09.21260260; doi: https://doi.org/10.1101/2021.07.09.21260260

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3290)
  • Dentistry and Oral Medicine (364)
  • Dermatology (278)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1170)
  • Epidemiology (13371)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (782)
  • Health Informatics (3266)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (430)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14625)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4922)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2523)
  • Ophthalmology (723)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4209)
  • Public and Global Health (7501)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1012)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)